![A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa - American Journal of Ophthalmology A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa - American Journal of Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2006219163/2028107464/gr1.gif)
A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa - American Journal of Ophthalmology
![Nanoscope Therapeutics Announces Completion of Enrollment in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease Nanoscope Therapeutics Announces Completion of Enrollment in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease](https://mma.prnewswire.com/media/1333752/Nanoscope_Therapeutics_Logo.jpg)
Nanoscope Therapeutics Announces Completion of Enrollment in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease
![Aldeyra Therapeutics Announces Positive Dry Eye Disease Pre-NDA Meeting with the FDA and Highlights Upcoming Corporate Milestones | Business Wire Aldeyra Therapeutics Announces Positive Dry Eye Disease Pre-NDA Meeting with the FDA and Highlights Upcoming Corporate Milestones | Business Wire](https://mms.businesswire.com/media/20220913006271/en/1570896/23/ALDX_logo_JPEG.jpg)
Aldeyra Therapeutics Announces Positive Dry Eye Disease Pre-NDA Meeting with the FDA and Highlights Upcoming Corporate Milestones | Business Wire
![PDF) Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa PDF) Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa](https://i1.rgstatic.net/publication/348359276_Intravitreal_autologous_mesenchymal_stem_cell_transplantation_a_non-randomized_phase_I_clinical_trial_in_patients_with_retinitis_pigmentosa/links/5ffb950892851c13fe02e33c/largepreview.png)
PDF) Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa
![Translational research in regenerative stem cell therapies for retinal degenerative diseases: from the swine animal model of retinal atrophy to clinical trials in human patients with age-related macular degeneration, retinitis pigmentosa and Translational research in regenerative stem cell therapies for retinal degenerative diseases: from the swine animal model of retinal atrophy to clinical trials in human patients with age-related macular degeneration, retinitis pigmentosa and](http://www.institutmacula.com/wp-content/uploads/Foto43_1.jpg)
Translational research in regenerative stem cell therapies for retinal degenerative diseases: from the swine animal model of retinal atrophy to clinical trials in human patients with age-related macular degeneration, retinitis pigmentosa and
![Aldeyra Therapeutics starts Phase 2 clinical trial of ADX-2191 for treatment of retinitis pigmentosa Aldeyra Therapeutics starts Phase 2 clinical trial of ADX-2191 for treatment of retinitis pigmentosa](https://cdn.sanity.io/images/0vv8moc6/ophtalmology/fa1b3e733deac19d8f8f9c60ae0c8edf64f995f1-353x143.jpg)
Aldeyra Therapeutics starts Phase 2 clinical trial of ADX-2191 for treatment of retinitis pigmentosa
![Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives - ScienceDirect Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1350946217300526-fx1.jpg)